THE 20TH CENTURY witnessed major advances in several
|
|
- Tabitha Floyd
- 5 years ago
- Views:
Transcription
1 JOURNAL OF BONE AND MINERAL RESEARCH Volume 22, Supplement 2, 2007 doi: /JBMR.07S American Society for Bone and Mineral Research Vitamin D Deficiency and Primary Hyperparathyroidism Shonni J Silverberg ABSTRACT: Temporally associated with the improvement in vitamin D nutrition in many Western countries in the mid-20th century, there was a change in many characteristics of primary hyperparathyroidism. Osteitis fibrosa cystica became a rare manifestation of what is now frequently an asymptomatic disease. At the same time, in patients with the disease, levels of PTH and parathyroid adenoma weights have fallen dramatically. In view of these observations and others, an association between vitamin D deficiency and severity of primary hyperparathyroidism has been proposed. Data support an association on two distinct levels. First, regardless of the clinical severity of primary hyperparathyroidism, the disease seems to be more severe in those with concomitant vitamin D deficiency. Second, vitamin D deficiency and insufficiency seem to be more prevalent in patients with primary hyperparathyroidism than in geographically matched populations. The association between vitamin D deficiency and primary hyperparathyroidism has clear implications. Co-existing vitamin D deficiency may cause the serum calcium level to fall into the normal range, which can lead to diagnostic uncertainty. With regard to management, preliminary data on vitamin D repletion in patients with mild primary hyperparathyroidism suggest that, in some cases, correction of vitamin D deficiency may be accomplished without worsening the underlying hypercalcemia. Vitamin D deficient patients undergoing parathyroidectomy are also at increased risk of postoperative hypocalcemia and hungry bone syndrome, which underscores the importance of preoperative assessment of vitamin D status in all patients with primary hyperparathyroidism. J Bone Miner Res 2007;22:S2;V100 V104. doi: /JBMR.07S202 Key Words: primary hyperparathyroidism, vitamin D deficiency, parathyroidectomy INTRODUCTION THE 20TH CENTURY witnessed major advances in several areas affecting skeletal metabolism. In the 1930s, the fortification of milk led to improved vitamin D nutrition in the United States and some Western European countries. This, in turn, led to a marked reduction in the incidence of rickets. Several decades later, with the introduction of the multichannel autoanalyzer, a new clinical phenotype of primary hyperparathyroidism was recognized. (1 3) Asymptomatic primary hyperparathyroidism (PHPT) quickly emerged as the most common presentation of this disorder in the United States and some other Western countries. As the clinical profile of PHPT evolved, the hallmark skeletal abnormality of this disorder, osteitis fibrosa cystica, became a rarity in the United States, although this manifestation of classical PHPT is still commonplace in some parts of the world. Symptomatic and severe PHPT persists, in particular, in regions where vitamin D deficiency remains endemic. In view of these observations, and supported by recent epidemiological data from around the world, some have proposed an association between vitamin D deficiency and the severity of PHPT. This review will summarize the data on the association of vitamin D nutrition and PHPT and point to areas where future study is needed. The author states that she has no conflicts of interest. A GLOBAL VIEW: MORE SEVERE DISEASE As the clinical phenotype of primary hyperparathyroidism has altered from a highly symptomatic to a largely asymptomatic disease, levels of PTH in the disease and parathyroid adenoma weights have fallen dramatically. Global geographic differences remain, however, in the biochemical and clinical features of PHPT. Both clinical and laboratory features of PHPT are more severe in those regions where vitamin D deficiency is endemic. (4 10) Rao et al. (4) surveyed data from PHPT patients from varied geographic locales and found an inverse association between the extent of elevation of serum PTH in affected patients and 25-hydroxyvitamin D [25(OH)D] levels (Fig. 1). Data from countries where vitamin D deficiency is widespread (such as India, Turkey, and Saudi Arabia) also suggest an inverse relationship between serum 25(OH)D levels and parathyroid adenoma weight. (4,6,10) However, it is clear that this relationship is more complex than these simple correlations might suggest. Indeed, adenoma weights were far greater in Indian than American patients with similar degrees of vitamin D deficiency, and adenoma weights were similar among in Indian patients with and without vitamin D deficiency. (4,11) Our group had the opportunity to compare two modern cohorts of patients with PHPT, one in New York City and the other in Beijing, China. (7) Although <20% of the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA. V100
2 VITAMIN D DEFICIENCY AND PRIMARY HYPERPARATHYROIDISM V101 FIG. 1. A global view of the association of PTH and 25(OH)D levels in studies of patients with primary hyperparathyroidism. PTH levels represent elevations above the upper limit of the assay normal range. Countries or cities on the x-axis represent the geographic locations where patients with primary hyperparathyroidism have been studied. To convert serum 25(OH)D values to nanomoles per liter, multiply by 2.5. Adapted from Rao et al. (4) American cohort were symptomatic (all with nephrolithiasis), 94% of Chinese patients had symptoms of PHPT. Fracture and osteitis fibrosa cystica were common. Biochemical evaluation showed several distinguishing features, among them profound vitamin D deficiency. The Chinese patients had marked hypercalcemia (serum calcium, 12.4 versus 10.7 mg/dl), dramatic elevations in PTH (21 versus 1.5 times the upper limit of normal), and severely depressed levels of 25(OH)D (8 versus 21 ng/ml; for conversion to nm, multiply by 2.5). In Brazil, examination of patients with severe PHPT confirmed that those with osteitis fibrosa cystica had significantly lower levels of 25(OH)D and significantly higher levels of PTH than did those without bone disease. (9) In addition to data supporting more severe clinical manifestations of PHPT in patients with vitamin D deficiency, there is accumulating evidence that low levels of vitamin D are more frequent among patients with PHPT than in non- PHPT control subjects. Boudou et al. (12) recently reported on 145 patients who underwent parathyroidectomy in France. In this group, serum 25(OH)D was reported to be low (<20 ng/ml) in 93% of patients compared with geographic norms in the French population, which estimate prevalence of vitamin D insufficiency at 38%. MILD PRIMARY HYPERPARATHYROIDISM FIG. 2. PTH levels differ by tertile of 25(OH)D in 124 patients with mild primary hyperparathyroidism (*ANOVA, p < ). Range of 25(OH)D levels (ng/ml) for each tertile are shown in text boxes within the bars. Adapted from Silverberg et al. (14) In the United States and other Western nations, PHPT today is generally a disorder characterized by mild hypercalcemia and few overt symptoms. However, there are clearly consequences when even mild PHPT exists with concomitant vitamin D insufficiency or deficiency. First, the co-existence of these findings may have diagnostic implications. Insufficient or frankly low vitamin D stores tend to oppose the effect of PHPT to increase serum and urinary calcium levels. This can lead to a reduction of these indices into the normal range, which may in turn lead to diagnostic confusion. Indeed, vitamin D deficiency may well be the most common explanation for the biochemical constellation seen in what may be thought to be normocalcemic PHPT. In fact, it is more appropriate to reserve the term normocalcemic PHPT for those patients who have no cause for secondary hyperparathyroidism. Ironically, some have suggested that the high prevalence of vitamin D insufficiency in such areas as Southern Europe may lead to an underestimation of the prevalence of PHPT, because the dearth of vitamin D causes elevated levels of serum calcium to decline into the normal range. (13) In such patients, PTH levels would not be measured, and the diagnosis of PHPT would not be pursued. As has been reported in more severe PHPT, there are data supporting an increased prevalence of vitamin D insufficiency in patients with disease characterized by mild hypercalcemia as well. In 124 patients with mild PHPT [mean values: serum calcium, 10.7 mg/dl; PTH, 121 pg/ml; 25(OH)D, 21 ng/ml], we found only 7% of patients to have levels of 25(OH)D that were below the assay normal limit (9 52 ng/ml). (14) However, over one half had 25(OH)D levels <20 ng/ml and fully 84% had 25(OH)D levels <30 ng/ml. Furthermore, we found that PTH levels were inversely associated with 25(OH)D concentrations, with those patients with the lowest levels of vitamin D having the most elevated PTH concentrations (Fig. 2). Consistent with the effect of excess PTH in this group, those with lowest vitamin D levels also had highest levels of alkaline phosphatase, lowest BMD at the distal one-third radius site, and highest mineralizing surface (% MS/BS) and extent of osteoid (% OS/ BS) on histomorphometric examination of transiliac crest bone biopsies. We found no association of 25(OH)D levels with the concentration of 1,25-dihydroxyvitamin D, which speaks against a role for enhanced conversion to the active moiety as an explanation for the low levels of 25(OH)D in PHPT. These data were extended by Moosegaard et al., (15) who also reported an increased prevalence of vitamin D deficiency in mild PHPT (N 289; mean serum calcium, 11.0 mg/dl; Fig. 3). Although they found no association of 25(OH)D levels with adenoma weight, they did report that low levels of this form of vitamin D were associated with evidence of increased disease severity. When controlled for age, sex, BMI, serum creatinine, and season, their data confirmed that low 25(OH)D concentrations were associated with increased PTH and alkaline phosphatase levels and also with lower BMD at both the femoral neck and radius. This group has also reported that parathyroid secretory activity in PHPT is related to circulating levels of 25(OH)D and not 1,25-dihydroxyvitamin D. (16) Although most current data on mild PHPT are suggestive, not all reports confirm an association of vitamin D
3 V102 SILVERBERG FIG. 3. Prevalence of vitamin D insufficiency and deficiency in mild primary hyperparathyroidism in comparison with agematched osteoporotic control subjects (Control) or healthy blood donors (Normal). *Difference from primary hyperparathyroid FIG. 4. Vitamin D repletion in primary hyperparathyroidism. group at p < Adapted from Moosegaard et al. (15) Effect of 12 mo of cholecalciferol on 25(OH)D and PTH levels in 21 patients. *Difference in PTH levels from pretreatment baseline. Adapted from Grey et al. (24) levels with skeletal indices. In a study of patients with somewhat more severe hypercalcemia [mean serum calcium: 11.4 mg/dl; mean 25(OH)D: 19 nm], Carnevale et al. (17) used a progressively restricted multivariate model to assess effects on BMD. They found that PTH concentration, age, and BMI had the predominant effects on bone mass, whereas 25(OH)D levels had no independent effect on BMD at any site. While confirming that 25(OH)D levels in the insufficiency and deficiency range were common in Japanese patients with mild PHPT (mean serum calcium, 10.8 mg/dl), Yamashita et al. (18) also found no differences in biochemical characteristics or bone densitometry according to vitamin D levels. One additional clinical feature of mild PHPT is worth mentioning with respect to vitamin D deficiency. Recent reports have suggested that 25(OH)D deficiency may be associated with worse cognition and lower mood in older adults. (19 21) It remains unclear whether the frequent finding of low levels of 25(OH)D might account for the neuropsychological complaints so common in patients with mild PHPT. MANAGEMENT Data have long been available suggesting that parathyroid function is responsive to the usual stimuli in PHPT. Over 20 yr ago, Insogna et al. (22) reported that, in PHPT, a calcium intake of 1000 mg/d was associated with a suppression of levels of both PTH and 1,25-dihydroxyvitamin D. To date, there are no data to support draconian restrictions of calcium and/or vitamin D intake in this disease. Indeed, further increases in PTH levels and perhaps further increase in parathyroid gland size could result from such an approach. Data on the repletion of vitamin D in deficient patients with PHPT are limited. Kantorovich et al. (23) found increased BMD at the spine and hip in five patients who had simultaneous low 25(OH)D and elevated PTH levels after therapy with vitamin D. This study was limited by its very small sample size. In addition, the presumptive diagnosis of PHPT is questionable in several patients. These subjects had serum calcium levels in the lower end of the normal range even after vitamin D repletion, raising the possibility that they had secondary rather than primary hyperparathyroidism. The more promising study of Grey et al. (24) did find benefits of vitamin D repletion in patients with typical mild PHPT (mean serum calcium, 10.8 mg/dl). This study treated a small cohort (N 21) of such patients with cholecalciferol, 50,000 units/wk for 4 wk, followed by 50,000 units monthly for the balance of a year. In association with the rise in 25(OH)D levels, PTH levels declined by 25%, without a concomitant increase in serum or urinary calcium in the group as whole (Fig. 4). It is important to note that one patient did have a significant rise in serum calcium, whereas three had markedly increased urinary calcium excretion (>400 mg/d) at some point during the study, highlighting the importance of careful monitoring of any patients with PHPT who are treated with vitamin D. These data suggest a potential benefit of vitamin D repletion in selected patients who are not planning to undergo parathyroidectomy and clearly call for confirmation and extension in larger clinical trials. In those patients undergoing surgery for PHPT, the presence of vitamin D deficiency/insufficiency has other implications. In the presence of vitamin D deficiency, there must be heightened concern about postparathyroidectomy hypocalcemia as a result of hungry bones. Whereas hungry bone syndrome was commonplace in classical PHPT, recent data are mixed on the association of preoperative D deficiency with postoperative hypocalcemia. (12,25) However, the repercussions in terms of postparathyroidectomy hyperparathyroidism are clear. Postoperative elevations in PTH levels are consistently associated with lower levels of vitamin D, whether measured before surgery (26,27) or immediately after surgical cure. (28) Rigorous trials of postoperative repletion of vitamin D in patients with concomitant vitamin D deficiency and PHPT have not been done. SUMMARY AND FUTURE DIRECTIONS The association of vitamin D deficiency and PHPT is evident on two distinct levels. First, in those with PHPT, the
4 VITAMIN D DEFICIENCY AND PRIMARY HYPERPARATHYROIDISM V103 disease seems to be more severe in those with concomitant vitamin D deficiency. PHPT is frequently symptomatic in areas where vitamin D deficiency is endemic, and osteitis fibrosa cystica remains a common feature of the disease. There are also data supporting increased severity of hyperparathyroidism in those patients with mild PHPT and concomitant vitamin D deficiency or insufficiency. Second, vitamin D deficiency and insufficiency seems to be more prevalent in patients with PHPT than in geographically matched populations. This is the case even in populations of patients with mild, asymptomatic PHPT that are more common in the United States today. However, because current data are all cross-sectional, it is not possible to determine causality of the association between vitamin D deficiency and PHPT. There have been many possible explanations put forth for this association, the details of which are beyond the scope of this report. (29 37) Chronic vitamin D deficiency has been proposed to lead to autonomous parathyroid gland stimulation with subsequent hyperplasia and eventual adenoma growth. Alternatively, chronic vitamin D deficiency could accelerate the growth of a preexisting adenoma. The increased levels of 1,25-dihydroxyvitamin D in PHPT have also been proposed to influence overall vitamin D status. Possible mechanisms might include an inhibition of the production of vitamin D 3 in skin, an inhibition of the production of 25-hydroxyvitamin D in the liver, or increased renal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. There are also data suggesting that the half-life of 25-hydroxyvitamin D is significantly shortened in PHPT, with increased metabolic clearance caused by enhanced hepatic inactivation. Finally, others point to decreased bioavailability of vitamin D in PHPT patients because of increased body weight. Although the cause, or more likely causes, of the association between vitamin D deficiency and PHPT remain obscure, the observation has clear management implications. Available data support the need for randomized trials of vitamin D repletion in patients with co-existing vitamin D deficiency and PHPT. These trials must assess possible benefits of such intervention (including any improvements in hip and forearm BMD and reduced fracture risk) against the potential risks of hypercalcemia, hypercalciuria, and kidney stones. Looking to the future, it is interesting to speculate on the potential consequences of shifts in the prevalence of these two conditions. It is unclear whether the increasing global prevalence of vitamin D insufficiency/deficiency will have an impact on the clinical picture of PHPT. At the same time, shifts in the use of multichannel biochemical screening may decrease the recognition of the truly asymptomatic patient with PHPT. Whether these shifts will be associated with a return to a clinically more severe phenotype of PHPT remains to be seen. ACKNOWLEDGMENTS SJS is supported by NIH Grants DK074457, K24 DK074457, and DK REFERENCES 1. Albright F, Reifenstein EC 1948 The Parathyroids Glands and Metabolic Bone disease. Williams and Wilkins, Baltimore, MD, USA. 2. Heath H, Hodgson SF, Kennedy MA 1980 Primary hyperparathyroidism incidence, morbidity and potential economic impact in a community. N Engl J Med 302: Silverberg SJ, Bilezikian JP 2001Clinical presentation of primary hyperparathyroidism in the United States. In: Bilezikian JP, Marcus R, Levine MA (eds.) The Parathyroids. Academic Press, New York, NY, USA, pp Rao DS, Agarwal G, Talpos GB, Phillips ER, Bandeira F, Mishra SK, Mithal A 2002 Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: A global perspective. J Bone Miner Res 17:S2;N75 N Harinarayan CV, Gupta N, Kochupillai N 1995 Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 43: Raef H, Ingemansson S, Sobhi S, Sutan A, Ahmed M, Chaudhry M 2004 The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism in a vitamin D deficient region. J Endocrinol Invest 27: Bilezikian JP, Meng X, Shi Y, Silverberg SJ 2000 Primary hyperparathyroidism in women: New York and Beijing- A Tale of Two Cities. Int J Fertil Womens Med 45: Mithal A, Bandeira F, Meng X, Silverberg S, Shi Y, Mishra SK, Griz L, Macedo G, Celdas G, Bandeira C, Bilezikian JP, Rao DS 2001 Clinical presentation of primary hyperparathyroidism: India, Brazil and China. In: Bilezikian JP, Levine MA, Marcus R (eds.) The Parathyroids, 2nd ed. Academic Press, San Diego, CA, USA, pp Bandeira F, Calcas G, Greese E, Griz L, Faria M, Bandeira C 2002 Relationship between serum vitamin D status and clinical manifestations of primary hyperparathyroidism. Endocr Pract 8: Ozbey N, Erbil Y, Ademoglu E, Ozarmagan S, Barbaros U, Bozbora A 2006 Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World J Surg 30: Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, Talpos GB, Parfitt AM 2000 Effect of vitamin D nutrition on parathyroid adenoma weight: Pathogenetic and clinical implications. J Clin Endocrinol Metab 85: Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC 2006 A very high incidence of low 25 hydroxyvitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 29: Adami S, Marcocci C, Gatti D 2002 Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17(Suppl 2):N18 N Silverberg SJ, Shane E, Dempster DW, Bilezikian JP 1999 The effects of vitamin D insufficiency in patients with primary hyperparathyroidism Am J Med 107: Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L 2005 Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63: Moosegaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L 2006 Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: A cross-sectional study. Eur J Endocrinol 155: Carnevale V, Manfredi G, Romagnoli E, DeGeronimo S, Paglia F, Pepe J, Scillitani A, D Erasmo E, Minisola S 2004 Vitamin D status in female patients with primary hyperparathyroidism: Does it play a role in skeletal damage? Clin Endocrinol (Oxf) 60: Yamashita H, Noguchi S, Uchno S, Watanabe S, Koike E, Murakami T, Fujihira T, Koga Y, Masatsugu T, Yamashita H
5 V Vitamin D status in Japanese patients with hyperparathyroidism World J Surg 26: Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J 2006 Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: The Tromso study. J Neurol 253: Przybelski RJ, Binkley NC 2007 Is vitamin D important for preserving cognition? A positive correlation of serum 25- hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460: Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC 2006 Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14: Insogna KL, Mitnick ME, Stewart AF, Burtis WJ, Mallette LE, Broadus AE 1985 Sensitivity of the parathyroid hormone 1,25- dihydoxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism. N Engl J Med 313: Kantorovich V, Gacad MA, Seeger LL, Adams JS 2000 Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 85: Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR 2005 Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 90: Stewart ZA, Blackford A, Somervell H, Friedman K, Garrett- Mayer E, Dackiw APB, Zieger MA hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 138: Bergenfelz A, Valdemarsson S, Tibblin S 1996 Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: Evidence of detrimental effects of severe parathyroid disease. Surgery 119: Denizot A, Pucini M, Chagnaud C, Botti G, Henry J 2001 Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 182: Wang TS, Ostrower ST, Heller KS 2005 Persistently elevated parathyroid hormone levels after parathyroid surgery. Surgery 138: SILVERBERG 29. Woodhouse NJY, Doyle FH, Joplin GF 1971 Vitamin D deficiency and primary hyperparathyroidism. Lancet 2: Lumb GA, Stanbury SW 1974 Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 56: Kleeman CR, Norris K, Coburn JW 1987 Is the clinical expression of primary hyperparathyroidism a function of the longterm vitamin D status of the patient? Miner Electrolyte Metab 13: Parfitt AM 2001 Parathyroid growth: Normal and abnormal. In: Bilezikian JP, Levine MA, Marcus R (eds.) The Parathyroids: Basic and Clinical Concepts. Academic Press, New York, NY, USA, pp Mosekilde L, Charles P, Lindegreen P 1989 Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone Miner 5: Lalor BC, Mawer EB, Davies M, Lumb GA, Hunt L, Adams PH 1989 Determinants of the serum concentration of 1,25- dihydroxyvitamin D in primary hyperparathyroidism. Clin Sci 76: Clements MR, Davies M, Frasier DR, Lumb GA, Mawer EB, Adams PH 1987 Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism Clin Sci 73: Bolland MJ, Grey AB, Gamble GD, Reid IR 2005 Association between primary hyperparathyroidism and increased body weight: A meta-analysis. J Clin Endocrinol Metab 90: Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick ME 2000 Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: Address reprint requests to: Shonni J Silverberg, MD Department of Medicine Columbia University College of Physicians and Surgeons 630 West 168th Street, PH8W-864 New York, NY 10032, USA E mail: sjs5@columbia.edu Received in original form February 7, 2007; revised form June 20, 2007; accepted October 19, 2007.
Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D
European Journal of Endocrinology (2009) 161 189 193 ISSN 0804-4643 CLINICAL STUDY Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D J R Tucci 1,2,3 1 Division of Endocrinology,
More informationVitamin D Therapy in Patients with Primary Hyperparathyroidism and Hypovitaminosis D
Page 1 of 17 Accepted Preprint first posted on 21 April 2009 as Manuscript EJE-08-0901 Vitamin D Therapy in Patients with Primary Hyperparathyroidism and Hypovitaminosis D JR Tucci, MD, FACP, FACE, Director,
More informationPrimary Hyperparathyroidism: A Tale of Two Cities Revisited New York and Shanghai
ORIGINAL ARTICLE Bone Research (2013) 2: 162-169. www.boneresearch.org Primary Hyperparathyroidism: A Tale of Two Cities Revisited New York and Shanghai Jian-min Liu 1, Natalie E. Cusano 2, Barbara C.
More informationHyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012
Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco
More information"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy
"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy Rebecca S. Sippel, M.D. Assistant Professor Department of Surgery Section of Endocrine Surgery University of Wisconsin Primary Hyperparathyroidism
More informationResearch Article Primary Hyperparathyroidism: 11-Year Experience in a Single Institute in Thailand
International Endocrinology Volume 2012, Article ID 952426, 4 pages doi:10.1155/2012/952426 Research Article Primary Hyperparathyroidism: 11-Year Experience in a Single Institute in Thailand Poramaporn
More information4/20/2015. The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy. Learning Objectives
The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning
More informationViral N. Shah*, Chirag S. Shah, Sanjay K. Bhadada and D. Sudhakar Rao
Clinical Endocrinology (2014) 80, 797 803 doi: 10.1111/cen.12398 ORIGINAL ARTICLE Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency
More informationPRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery
ENDOCRINE DISORDER PRIMARY HYPERPARATHYROIDISM Roseann P. Velez, DNP, FNP Francis J. Velez, MD, FACS Common Complex Insidious Chronic Global Only cure is surgery HYPERPARATHYROIDISM PARATHRYOID GLANDS
More informationIndian Journal of Endocrinology & Metabolism
Spine 6.5 mm ISSN 2230-8210 Vol. 20 Issue 5 September-October 2016 Indian Journal of Endocrinology and Metabolism Indian Journal of Endocrinology & Metabolism www.ijem.in Volume 20 Issue 5 September-October
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1999, by the Massachusetts Medical Society VOLUME 341 O CTOBER 21, 1999 NUMBER 17 A 10-YEAR PROSPECTIVE STUDY OF PRIMARY HYPERPARATHYROIDISM WITH OR WITHOUT
More informationDo We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital
Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 13, 2017 Disclosures statement: Consultant: Allena, Becker
More informationORIGINAL ARTICLE. Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism
Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism Elizabeth A. Mittendorf, MD; Christopher R. McHenry, MD ORIGINAL ARTICLE Background: Persistent
More informationUPDATES ON PRIMARY HYPERPARATHYROIDISM. Natalie E. Cusano, MD, MS Director, Bone Metabolism Program Lenox Hill Hospital New York, NY
UPDATES ON PRIMARY HYPERPARATHYROIDISM Natalie E. Cusano, MD, MS Director, Bone Metabolism Program Lenox Hill Hospital New York, NY Disclosures Speaker (Honorarium): Shire Off-label use of estrogen, raloxifene
More informationCase 2: 30 yr-old woman with 7 yr history of recurrent kidney stones
Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) 30 yr-old woman with 7 yr history
More informationParathyroid Imaging. A Guide to Parathyroid Surgery
Parathyroid Imaging A Guide to Parathyroid Surgery Primary Hyperparathyroidism (PHPT) 3 rd most common endocrine disorder after diabetes and hyperthyroidism Prevalence in women 2% Often discovered in asymptomatic
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014
HYPOVITAMINOSIS D IN INDIAN FEMALES WITH POSTMENOPAUSAL OSTEOPOROSIS DR. SHAH WALIULLAH 1 DR. VINEET SHARMA 2 DR. R N SRIVASTAVA 3 DR. YASHODHARA PRADEEP 4 DR. A A MAHDI 5 DR. SANTOSH KUMAR 6 1 Research
More informationApproach to a patient with hypercalcemia
Approach to a patient with hypercalcemia Ana-Maria Chindris, MD Division of Endocrinology Mayo Clinic Florida 2013 MFMER slide-1 Background Hypercalcemia is a problem frequently encountered in clinical
More informationPAPER. Conclusion: Although one-third of the patients had elevated
PAPER Long-term Outcome of Patients With Elevated Parathyroid Hormone Levels After Successful Parathyroidectomy for Sporadic Primary Hyperparathyroidism Carmen C. Solorzano, MD; William Mendez, MD; John
More informationhypercalcemia of malignancy hyperparathyroidism PHPT the most common cause of hypercalcemia in the outpatient setting the second most common cause
hyperparathyroidism A 68-year-old woman with documented osteoporosis has blood tests showing elevated serum calcium and parathyroid hormone (PTH) levels: 11.2 mg/dl (8.8 10.1 mg/dl) and 88 pg/ml (10-60),
More informationNormal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease?
Ann Surg Oncol (2011) 18:3437 3442 DOI 10.1245/s10434-011-1744-x ORIGINAL ARTICLE ENDOCRINE TUMORS Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease? Amanda L. Amin, MD, Tracy S.
More informationAwaisheh. Mousa Al-Abbadi. Abdullah Alaraj. 1 Page
f #3 Awaisheh Abdullah Alaraj Mousa Al-Abbadi 1 Page *This sheet was written from Section 1 s lecture, in the first 10 mins the Dr. repeated all the previous material relating to osteoporosis from the
More informationEffects of surgery on outcome of primary hyperparathyroidism
1 Effects of surgery on outcome of primary hyperparathyroidism Peter Vestergaard Leif Mosekilde Peer Christiansen Introduction Primary hyperparathyroidism is a disease with effects on many organ systems
More informationDesign: This was a longitudinal cohort study. Setting: The study took place at a referral center.
ORIGINAL ARTICLE Endocrine Care Bone Mineral Density Evolution After Successful Parathyroidectomy in Patients With Normocalcemic Primary Hyperparathyroidism Eugénie Koumakis, Jean-Claude Souberbielle,
More informationChallenges in the Management of Primary HPTH. Zaher Ajam, MD Ghada El-Hajj Fuleihan, MD, MPH
Challenges in the Management of Primary HPTH Zaher Ajam, MD Ghada El-Hajj Fuleihan, MD, MPH Case Presentation 1 This a case of a 41-year-old gentleman who is referred to Endocrinology clinic for low BMD,
More informationPrimary Hyperparathyroidism
Primary Hyperparathyroidism Copyright Copyright 2019 2019 American American Associa7on Associa7on of Clinical of Clinical Endocrinologists Endocrinologists 1 Primary Hyperparathyroidism In primary hyperparathyroidism
More informationCurrent Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012.
Current Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012 Disclosures I have no financial relationships with commercial interests,
More informationElena Castellano, Roberto Attanasio, Laura Gianotti, Flora Cesario, Francesco Tassone, and Giorgio Borretta
ORIGINAL ARTICLE Forearm DXA Increases the Rate of Patients With Asymptomatic Primary Hyperparathyroidism Meeting Surgical Criteria Elena Castellano, Roberto Attanasio, Laura Gianotti, Flora Cesario, Francesco
More informationBone and Renal Stone Disease in Patients Operated for Primary Hyperparathyroidism in Pakistan: Is the Pattern of Disease different from the West?
ecommons@aku Section of Urology Department of Surgery August 1999 Bone and Renal Stone Disease in Patients Operated for Primary Hyperparathyroidism in Pakistan: Is the Pattern of Disease different from
More informationAsymptomatic Primary Hyperparathyroidism
The new england journal of medicine clinical practice Asymptomatic Primary Hyperparathyroidism John P. Bilezikian, M.D., and Shonni J. Silverberg, M.D. This Journal feature begins with a case vignette
More informationSummary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century
Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century John P. Bilezikian, John T. Potts, Jr., Ghada El-Hajj Fuleihan, Michael Kleerekoper, Robert
More informationCalcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationMinimally invasive parathyroidectomy
Minimally invasive parathyroidectomy Jessica E. Gosnell MD Assistant Professor of Surgery March 22, 2011 1 Minimally invasive parathyroidectomy 1. What? 2. When? 3. How? 4. Convert? 5. What adjuncts? Primary
More informationCase Report A Reference Finding Rarely Seen in Primary Hyperparathyroidism: Brown Tumor
Case Reports in Medicine Volume 2012, Article ID 432676, 4 pages doi:10.1155/2012/432676 Case Report A Reference Finding Rarely Seen in Primary Hyperparathyroidism: Brown Tumor F. Mantar, 1 S. Gunduz,
More informationPRIMARY HYPERPARATHYROIDISM
PRIMARY HYPERPARATHYROIDISM HYPERPARATHYROIDISM Inappropriate excess secretion of Parathyroid Hormone in Primary Hyperparathyroidism Appropriate Hypersecretion in Secondary Hyperparathyroidism PTH and
More informationParathyroid Disease Scenarios for the Practicing Clinician. Vijaya Chockalingam MD Faculty Endocrinologist Banner University Medical Center- Phoenix
Parathyroid Disease Scenarios for the Practicing Clinician Vijaya Chockalingam MD Faculty Endocrinologist Banner University Medical Center- Phoenix Clinical Scenario-1 73 year man (BK) with hypercalcemia
More informationThe disease spectrum in primary hyperparathyroidism
Original Article Symptomatic Primary Hyperparathyroidism : A Retrospective Analysis of Fifty One Cases from a Single Centre J Muthukrishnan*, Sangeeta Jha*, KD Modi*, R Jha**, J Kumar**, A Verma*, KVS
More informationVitamin D and Calcium Therapy: how much is enough
Vitamin D and Calcium Therapy: how much is enough Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco DISCLOSURE Nothing to disclose 1 RECOMMENDATIONS
More informationSince the advent of multichannel serum chemistry
ONLINE EXCLUSIVE Padmaja Sanapureddy, MD; Vishnu Vardhan Garla, MD; Mallikarjuna Reddy Pabbidi, DVM, PhD Department of Primary Care and Medicine, G.V. (Sonny) Montgomery VA Medical Center, Jackson, Miss
More informationThe Endocrine Society Guidelines
Vitamin D and Calcium Therapy: how much is enough DISCLOSURE Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco Nothing to disclose RECOMMENDATIONS
More informationRadiographic Appearance Of Primary Hyperparathyroidism With Atypical Parathyroid Adenoma
ISPUB.COM The Internet Journal of Internal Medicine Volume 6 Number 2 Radiographic Appearance Of Primary Hyperparathyroidism With Atypical Parathyroid Adenoma P George, N Philip, B Pawar Citation P George,
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 116 No 1179 ISSN 1175 8716 Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency Fiona Wu, Toni Staykova, Anne Horne, Judy Clearwater,
More informationClinical Approach to Hypercalcemia For the Primary Care Provider
Clinical Approach to Hypercalcemia For the Primary Care Provider Christina Maser, MD FACS UCSF Fresno Department of Surgery, Endocrine Surgery 2/2/19 Objectives Recognition of pitfalls of diagnosis of
More informationCoexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park
J Korean Surg Soc 2011;81:316-320 http://dx.doi.org/10.4174/jkss.2011.81.5.316 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Coexistence of parathyroid
More informationHypercalcemia. Hypercalcemia: When to Worry, When to Treat! Mineral Metabolism : A Short Course
Hypercalcemia: When to Worry, When to Treat! Michael A. Levine has no financial relationships to disclose or Conflicts of Interest to resolve. Michael A. Levine, M.D. This presentation will not involve
More informationORIGINAL ARTICLE. Severity, Clinical Significance, Relationship to Primary Hyperparathyroidism, and Response to Parathyroidectomy
ORIGINAL ARTICLE Osteoporosis in Multiple Endocrine Neoplasia Type Severity, Clinical Significance, Relationship to Primary Hyperparathyroidism, and Response to Parathyroidectomy John R. Burgess, MD, FRACP;
More informationPersistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019
Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal
More informationThe Impact of Vitamin D Status on Preoperative Ultrasound Findings and Parathyroidectomy Outcomes in Patients With Primary Hyperparathyroidism
Original Article J Endocrinol Metab. 2017;7(6):172-177 The Impact of Vitamin D Status on Preoperative Ultrasound Findings and Parathyroidectomy Outcomes in Patients With Primary Hyperparathyroidism Ashutosh
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism
Southern Derbyshire Shared Care Pathology Guidelines Primary Hyperparathyroidism Please use this Guideline in Conjunction with the Hypercalcaemia Guideline Definition Driven by hyperfunction of one or
More information2016 Arizona AACE Meeting: Updated Guidelines for the Management of Primary Hyperparathyroidism (PHPT)
2016 Arizona AACE Meeting: Updated Guidelines for the Management of Primary Hyperparathyroidism (PHPT) Scott M. Wilhelm, MD, FACS Associate Professor and Section Head Endocrine Surgery University Hospitals-Cleveland
More informationHYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE
HYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE PROFESSOR OF SURGERY J I N N A H S I N D H M E D I C A L U N I V E R S I T Y PREAMBLE Anatomy & physiology of the
More informationOutline. The Role of Vitamin D in CKD. Essential Role of Vitamin D. Mechanism of Action of Vit D. Mechanism of Action of Vit D 7/16/2010
Outline The Role of Vitamin D in CKD Priscilla How, Pharm.D., BCPS Assistant Professor National University of Singapore Principal Clinical Pharmacist National University Hospital (Pharmacy and Nephrology,
More informationInternational Journal of Biological & Medical Research. An Uncommon Case of Persistent Hypercalcaemia following Parathyroid Surgery
Int J Biol Med Res.2015;6(4):5336-5340 Int J Biol Med Res www.biomedscidirect.com Volume 6, Issue 2, April 2015 Contents lists available at BioMedSciDirect Publications International Journal of Biological
More informationCases in Endocrinology
Bones, Moans and Groans Diagnosing and Treating Primary Hyperparathyroidism By M. Usman Chaudhry, MD Table 1 Laboratory parameters Her bone density had osteopenic T-Scores of -2.3 at lumbar spine, and
More informationOSTEOMALACIA UPDATE. Nothing to Disclose. Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco
OSTEOMALACIA UPDATE Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco Nothing to Disclose 1 Case History 59 YO WM referred for evaluation of diffuse
More informationPrimary hyperparathyroidism is mild disease worth treating?
CONFERENCE SUMMARIES Clinical Medicine 2010, Vol 10, No 1: 45 9 Primary hyperparathyroidism is mild disease worth treating? NJL Gittoes and MS Cooper ABSTRACT Most patients with primary hyperparathyroidism
More informationPapers. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study Charlotte L Mollerup, Peter Vestergaard, Vibe Gedsø Frøkjær, Leif
More informationHyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE
Hyperparathyroidism When to Suspect, How to Diagnose, When and How to Intervene Johanna A. Pallotta, MD, FACP, FACE Potential conflicts of interest: None Johanna A. Pallotta, MD Outline Definition of hyperparathyroidism
More informationPredictors of Renal Function in Primary Hyperparathyroidism
ORIGINAL Endocrine ARTICLE Research Predictors of Renal Function in Primary Hyperparathyroidism Marcella D. Walker, Thomas Nickolas, Anna Kepley, James A. Lee, Chiyuan Zhang, Donald J. McMahon, and Shonni
More informationVitamin D and primary hyperparathyroidism (PHPT)
Disponible en ligne sur www.sciencedirect.com Annales d Endocrinologie 73 (2012) 165 169 Review Vitamin D and primary hyperparathyroidism (PHPT) Vitamine D et hyperparathyroïdie primitive (HPP) Jean-Claude
More informationHYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences
HYPERCALCEMIA Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences ESSENTIALS OF DIAGNOSIS Serum calcium level > 10.5 mg/dl Serum ionized
More informationASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM: STANDARDS AND GUIDELINES FOR DIAGNOSIS AND MANAGEMENT IN CANADA
Position Paper ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM: STANDARDS AND GUIDELINES FOR DIAGNOSIS AND MANAGEMENT IN CANADA Consensus Development Task Force on Diagnosis and Management of Asymptomatic Primary
More informationVITAMIN D AND THE ATHLETE
VITAMIN D AND THE ATHLETE CONSIDERATIONS FOR THE PRACTITIONER Written by Bruce Hamilton, Qatar Vitamin D is a steroid hormone that has previously been given little attention, partially as a result of its
More informationCurrent Status and Treatment
Review article Current Status and Treatment of Primary Hyperparathyroidism By Dina M Elaraj, MD Orlo H Clark, MD Abstract Primary hyperparathyroidism (HPT) is diagnosed in approximately 100,000 patients
More informationCKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow
CKD: Bone Mineral Metabolism Peter Birks, Nephrology Fellow CKD - KDIGO Definition and Classification of CKD CKD: abnormalities of kidney structure/function for > 3 months with health implications 1 marker
More informationIn highly resourced health care systems, in which serum calcium is
The new england journal of medicine Clinical Practice Caren G. Solomon, M.D., M.P.H., Editor Primary Hyperparathyroidism Karl L. Insogna, M.D. This Journal feature begins with a case vignette highlighting
More informationDiagnosis and Management of Primary Hyperparathyroidism Clinical Practice Today CME
Diagnosis and Management of Primary Hyperparathyroidism Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Identify patients with primary hyperparathyroidism
More informationPlasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism
European Journal of Endocrinology (2008) 159 719 727 ISSN 0804-4643 CLINICAL STUDY Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and
More informationHypercalcemia may be detected incidentally. Practice CMAJ. Primary hyperparathyroidism. Primer. Key points. The case. What causes hypercalcemia?
CMAJ Practice Primer Primary hyperparathyroidism Hafsah Al-Azem HBSc, Aliya Khan MD The case A 17-year-old man presented at the clinic with thirst, lethargy and fatigue that had been ongoing for several
More informationDIAGNOSING X-LINKED HYPOPHOSPHATEMIA (XLH) BIOCHEMICAL TESTING CONSIDERATIONS
DIAGNOSING X-LINKED HYPOPHOSPHATEMIA (XLH) BIOCHEMICAL TESTING CONSIDERATIONS XLH IS CHARACTERIZED BY CHRONIC HYPOPHOSPHATEMIA XLH is a hereditary, progressive, lifelong disorder. In children and adults,
More informationPrimary Hyperparathyroidism, 2018: A Comprehensive Update
Primary Hyperparathyroidism, 2018: A Comprehensive Update John P. Bilezikian, MD, PhD(hon) Silberberg Professor of Medicine Vice-Chair for International Education and Research Chief, Division of Endocrinology,
More informationOutline. Parathyroid Localization Studies. Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center
Parathyroid Localization Studies Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center Outline Clinical Context of Primary Hyperparathyroidism Ultrasound, Sestamibi, and Other
More informationIperparatiroidismo normocalcemico: vero o falso?
Iperparatiroidismo normocalcemico: vero o falso? Bari, 7-10 novembre 2013 TERAPIA E FOLLOW-UP A. Piovesan SCDU Endocrinologia Oncologica AO Città della Salute e della Scienza Molinette Torino THE THIRD
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationShon E. Meek, M.D., Ph.D. Assistant Professor of Medicine
Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine meek.shon@mayo.edu 2016 MFMER 3561772-1 Update on Vitamin D Shon Meek MD, PhD 20 th Annual Endocrine Update January 30-Feb 3, 2017 Disclosure Relevant
More informationPrimary Hyperparathyroidism
Primary Hyperparathyroidism Claudio Marcocci, M.D., and Filomena Cetani, M.D., Ph.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various
More informationWhen the level of calcium in the blood falls too low, the parathyroid glands secrete just enough PTH to restore the blood calcium level.
Hyperparathyroidism Primary hyperparathyroidism is a disorder of the parathyroid glands, also called parathyroids. Primary means this disorder originates in the parathyroids: One or more enlarged, overactive
More information73 year-old Female with Hypercalcemia
73 year-old Female with Hypercalcemia Katie O Sullivan, M.D. Fellow, Adult/Pediatric Endocrinology University of Chicago Thursday, December 19 th, 2013 Chief Complaint 73 year-old female who presents for
More informationSecondary Hyperparathyroidism: Where are we now?
Secondary Hyperparathyroidism: Where are we now? Dylan M. Barth, Pharm.D. PGY-1 Pharmacy Resident Mayo Clinic 2017 MFMER slide-1 Objectives Identify risk factors for the development of complications caused
More informationHypercalciuria May Persist After Successful Parathyroid Surgery and It Is Associated With Parathyroid Hyperplasia
ORIGINAL ARTICLE Hypercalciuria May Persist After Successful Parathyroid Surgery and It Is Associated With Parathyroid Hyperplasia Serena Palmieri, Cristina Eller-Vainicher, Elisa Cairoli, Valentina Morelli,
More informationUpdate on vitamin D. J Chris Gallagher Professor of Medicine and Endocrinology Creighton University Omaha,Nebraska USA
Update on vitamin D J Chris Gallagher Professor of Medicine and Endocrinology Creighton University Omaha,Nebraska 68131 USA Cali, Colombia 2016 definitions DRIs are the recommended dietary reference intakes
More informationHYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY
UK RENAL PHARMACY GROUP SUBMISSION TO THE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE on CINACALCET HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE
More informationPRIMARY HYPERPARATHYROIDISM WITH RICKETS. KRITHIKA.P Dr.L.N.Padmasani Unit 1 Sri Ramachandra Medical College
PRIMARY HYPERPARATHYROIDISM WITH RICKETS KRITHIKA.P Dr.L.N.Padmasani Unit 1 Sri Ramachandra Medical College Presenting Complaints v 17 year old developmentally normal adolescent boy, first of a twin pregnancy,
More informationLONG-LASTING ADVANCED PRIMARY HYPERPARATHYROIDISM ASSOCIETED WITH END-STAGE RENAL FAILURE IN A DIABETIC PATIENT
LONG-LASTING ADVANCED PRIMARY HYPERPARATHYROIDISM ASSOCIETED WITH END-STAGE RENAL FAILURE IN A DIABETIC PATIENT H. Nasri * and A. Baradaran 1) Department of Nephrology, School of Medicine, Shahrekord University
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationRole of Imaging in the Localization of Parathyroid Adenoma
Role of Imaging in the Localization of Parathyroid Adenoma Authors S A Kabir 1, Z Khanzada 2, S I Akhtar 3, S I Kabir 4, N Wariach 1, 1. Department of Surgery, Lincoln County Hospital, Lincoln LN2 5QY,
More informationPituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs
Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs Shereen Ezzat, MD, FRCP(C), FACP Professor Of Medicine & Oncology Head, Endocrine Oncology Princess Margaret Hospital/University
More informationVitamin D Deficiency. Decreases renal calcium excretion. Increases intestinal absorption Calcium. Increases bone resorption of calcium
Vitamin D Deficiency Deborah Gordish, MD Assistant Professor of Clinical Internal Medicine Lead Physician Lewis Center Primary Care Associate Division Director General Internal Medicine The Ohio State
More informationThe Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels
CLINICAL RESEARCH STUDY The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels Walid Saliba, MD, MPH, a Ofra Barnett, PhD, a Hedy S. Rennert, MPH, a Idit Lavi, MA, a Gad Rennert, MD, PhD
More informationESPEN Congress Prague 2007
ESPEN Congress Prague 2007 Key papers in the field of nutrition Dietitian Geila S Rozen Key Papers in the field of Nutrition ESPEN 2007 Prague Geila S Rozen Clinical Nutrition Dep. Rambam health campus
More informationAdenoma weight and biochemical parameters in primary hyperparathyroidism
Original Research Medical Journal of Islamic Republic of Iran, Vol. 25, No. 3, Nov. 2011, pp. 136-141 Adenoma weight and biochemical parameters in primary hyperparathyroidism Downloaded from mjiri.iums.ac.ir
More informationMOST PATIENTS WITH primary hyperparathyroidism
0013-7227/03/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 88(3):1174 1178 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/jc.2002-020667 Raloxifene Lowers Serum Calcium
More informationSensipar. Sensipar (cinacalcet) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.46 Subject: Sensipar Page: 1 of 5 Last Review Date: June 22, 2018 Sensipar Description Sensipar (cinacalcet)
More informationNews on the treatment of HPT
News on the treatment of HPT G.C. Torre XIV Annual Conference of EES Tourin 25-27 November 2010 Epidemiology Prevalence: Sweeden = 4.3 /1000 Norway = 3/1000 Finland = 21/1000 USA = 1/1000 Italy = 5/1000
More informationDisclosure. Primary Hyperparathyroidism 4 th IW. Topic Outline. Calcium, Vitamin D, PTH Disorders. I have nothing to disclose related to this topic
Disclosure Calcium, Vitamin D, PTH Disorders Chienying Liu MD Associate Clinical Professor Division of Endocrinology & Metabolism UCSF I have nothing to disclose related to this topic Topic Outline Calcium/Vitamin
More informationNormocalcemic primary hyperparathyroidism: A newly emerging disease needing therapeutic intervention
HORMONES 2012, 11(4):390-396 Review Normocalcemic primary hyperparathyroidism: A newly emerging disease needing therapeutic intervention Gonzalo Díaz-Soto, 1 María Teresa Julián, 2 Manel Puig-Domingo 2
More informationSupplement DS1 Search strategy. EMBASE Search Strategy
British Journal of Psychiatry doi: 10.1192/bjp.bp.111.106666 Vitamin D deficiency and depression in adults: systematic review and meta-analysis Rebecca E. S. Anglin, Zainab Samaan, Stephen D. Walter and
More informationTABLE 1. Signs and Symptoms of Primary Hyperparathyroidism 1,2,4,5 Neurologic Inability to concentrate Confusion Depression Anxiety Fatigue Cardiovasc
CONCISE REVIEW FOR CLINICIANS NONSURGICAL MANAGEMENT OF HYPERPARATHYROIDISM Nonsurgical Management of Primary Hyperparathyroidism BRYAN FARFORD, DO; R. JOHN PRESUTTI, DO; AND THOMAS J. MORAGHAN, MD Primary
More informationClinical Medicine Insights: Endocrinology and Diabetes 2013:6
Open Access: Full open access to this and thousands of other papers at http://www.la-press.com. Clinical Medicine Insights: Endocrinology and Diabetes Epidemiology of Primary Hyperparathyroidism and its
More informationKobe University Repository : Kernel
Title Author(s) Citation Issue date 2009-09 Resource Type Resource Version DOI URL Kobe University Repository : Kernel Marked increase in bone formation markers after cinacalcet treatment by mechanisms
More information